Barry J. Moze's most recent trade in Horizon Therapeutics Plc was a trade of 64,959 Ordinary Shares done . Disclosure was reported to the exchange on Jan. 5, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2022 | 64,959 | 140,640 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.84 per share. | 05 Jan 2022 | 49,841 | 138,174 (0%) | 0% | 101.8 | 5,075,807 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 47,375 | 188,015 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2022 | 24,650 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2022 | 12,095 | 12,095 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2022 | 9,678 | 4,834 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2022 | 9,314 | 18,628 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2022 | 9,222 | 9,223 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 72,300 | 0 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.48 per share. | 04 Nov 2021 | 72,300 | 151,424 (0%) | 0% | 14.5 | 1,046,904 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 110.17 per share. | 04 Nov 2021 | 23,382 | 128,042 (0%) | 0% | 110.2 | 2,575,995 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 113.56 per share. | 04 Nov 2021 | 17,867 | 88,168 (0%) | 0% | 113.6 | 2,028,977 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 111.75 per share. | 04 Nov 2021 | 15,856 | 112,186 (0%) | 0% | 111.8 | 1,771,908 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 114.43 per share. | 04 Nov 2021 | 6,763 | 81,405 (0%) | 0% | 114.4 | 773,890 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 112.60 per share. | 04 Nov 2021 | 6,151 | 106,035 (0%) | 0% | 112.6 | 692,603 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 115.45 per share. | 04 Nov 2021 | 5,724 | 75,681 (0%) | 0% | 115.5 | 660,836 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 3,000 | 162,181 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 04 Nov 2021 | 3,000 | 78,681 (0%) | 0% | 22.1 | 66,420 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 443 | 0 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.81 per share. | 04 Nov 2021 | 443 | 79,124 (0%) | 0% | 11.8 | 5,232 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 14,514 | 14,514 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 7,257 | 78,896 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.50 per share. | 28 Jul 2021 | 3,215 | 75,681 (0%) | 0% | 102.5 | 329,538 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 93.12 per share. | 08 Jul 2021 | 14,626 | 71,639 (0%) | 0% | 93.1 | 1,361,973 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 92.64 per share. | 08 Jul 2021 | 12,350 | 86,265 (0%) | 0% | 92.6 | 1,144,104 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 91.35 per share. | 08 Jul 2021 | 8,100 | 98,615 (0%) | 0% | 91.4 | 739,935 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 88.70 per share. | 12 Apr 2021 | 51,253 | 120,025 (0%) | 0% | 88.7 | 4,546,136 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 89.60 per share. | 12 Apr 2021 | 8,195 | 111,830 (0%) | 0% | 89.6 | 734,242 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 90.30 per share. | 12 Apr 2021 | 6,165 | 105,665 (0%) | 0% | 90.3 | 556,671 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 14,512 | 14,512 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,931 | 3,931 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,965 | 172,149 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.17 per share. | 17 Feb 2021 | 871 | 171,278 (0%) | 0% | 87.2 | 75,925 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 5,819 | 5,821 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 5,819 | 172,762 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.43 per share. | 21 Jan 2021 | 2,578 | 170,184 (0%) | 0% | 77.4 | 199,615 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 65,089 | 219,801 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 54,003 | 154,712 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.10 per share. | 04 Jan 2021 | 52,858 | 166,943 (0%) | 0% | 36.1 | 1,908,174 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 27,942 | 27,942 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 24,649 | 24,650 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 17,260 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 12,094 | 24,190 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 78.37 per share. | 05 Nov 2020 | 41,189 | 137,020 (0%) | 0% | 78.4 | 3,228,097 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 79.03 per share. | 05 Nov 2020 | 27,764 | 109,256 (0%) | 0% | 79.0 | 2,194,095 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 81.58 per share. | 05 Nov 2020 | 6,553 | 100,709 (0%) | 0% | 81.6 | 534,572 | Ordinary Shares |
| Horizon Therapeutics Plc | Barry J. Moze | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 80.49 per share. | 05 Nov 2020 | 1,994 | 107,262 (0%) | 0% | 80.5 | 160,495 | Ordinary Shares |